GENTA INCORPORATED /DE/
4, 1998-08-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 4, 1998-08-10
Next: RANES INTERNATIONAL HOLDINGS INC, S-8, 1998-08-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   The, Aries Trust
   c/o Paramount Asset Management. inc.
   787 Seventh Avenue, 48th Floor
   New York, NY  10019
   
2. Issuer Name and Ticker or Trading Symbol
   Genta Incorporated
   GNTA
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   JULY / 1998
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
Series  A Convertible |$8.27   |7/27/|P   | |30,000     |A  |N/A  |N/A  |Common Stock|217,654|$7.50  |66,000      |D  |            |
Preferred Stock, par v|        |98   |    | |           |   |     |     |            |       |       |            |   |            |
alue $.001 per share  |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:

     

SIGNATURE  OF  REPORTING  PERSON  
/s/Lindsay  A.  Rosenwald,  M.D.
- --------------------------------------------
Lindsay  A.  Rosenwald,  M.D.,  President
Paramount  Capital Asset  Management,  Inc.,
Investment  Manager The Aries Trust 
DATE 
8/10/98

**   Intentional misstatements or omissions of facts constitute Federal Criminal
     Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed.
        If space provided is insufficient, see Instruction 6 for procedure.
 
Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.

<PAGE>

                                  Attachment A


                  Reporting Person:         The Aries Trust
                  Issuer:                   Genta Incorporated (GNTA)
                  Statement For:            July 1998

         Paramount Capital Asset Management, Inc. ("Paramount"), the
Investment Manager to The Aries Trust (the "Trust"), is also the General Partner
of the Aries Domestic Fund (the "Partnership"),  a Delaware limited partnership,
which also owns  securities of the Issuer.  Lindsay A.  Rosenwald,  M.D., is the
sole shareholder of Paramount.  Paramount and Dr. Rosenwald disclaim  beneficial
ownership of the securities held by the Partnership and the Trust, except to the
extent of their pecuniary interest therein.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission